Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (1)
- Past Events (1)
Guidance (152)
- Administering (11)
- Dosing (2)
- Medication Safety (1)
- Patient Group Directions (152)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (94)
- Explainer videos (4)
- Research and audits (3)
- Templates (87)
Specialty (79)
- Infection and infectious diseases (31)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (4)
Training and Development (6)

UK Health Security Agency (UKHSA) PGD Templates

8 April 2024Patient Group Direction templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.

Off-label or unlicensed product use under HMR 2012 exemptions

8 April 2024A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Using medicines under PGD as part of a clinical trial or study

8 April 2024Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

PGD use in Hospital at Home services, including Virtual Wards

8 April 2024Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

Patient Group Directions in Complex Commissioning Scenarios

8 April 2024This guide supports planning, decision making and advises on governance processes when PGDs are used within commissioned services.

Managing Patient Group Directions following amendments or changes

8 April 2024There are requirements for all PGDs to be resigned or reauthorised after any amendment or change made during its valid to/from dates

SPS National Patient Group Direction (PGD) exemplar templates

8 April 2024The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation

Fusidic acid 2% cream for impetigo

1 February 2024SPS PGD template for the supply of fusidic acid 2% cream for localised impetigo.

Otigo (phenazone with lidocaine) ear drops for otitis media

1 February 2024SPS PGD template for the supply of Otigo (phenazone with lidocaine) ear drops for symptomatic relief of pain due to otitis media.

Amoxicillin for otitis media

1 February 2024SPS PGD template for the supply of amoxicillin for otitis media.